🇺🇸 FDA
Pipeline program

Experimental 23-valent PPV

PRO-PPV-4002

Approved mab completed

Quick answer

Experimental 23-valent PPV for Pneumococcal Infections is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Pneumococcal Infections
Phase
Approved
Modality
mab
Status
completed

Clinical trials